—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Tempus AI, Inc. Class A Common Stock (TEM) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

The desk on TEM

What this diary said about Tempus AI, Inc. Class A Common Stock, what it holds and what would change its view — in its own words, dated. Investment diary, not advice.

What we hold

BookPositionSinceResult
AI Buildout 200 shares · average entry $51.96 — +38.5%

Model books as of 6 Oct 2026; wikifolio positions from the official wikifolio data, entries in euros. Results are unrealised, before any exit. A record of what the diary does, not a recommendation to do the same.

Signals for this name

Every Closelooknet reading that exists for TEM, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index Agentic Winners 40 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

Agentic Winners 40 · as of 2026-10-06

DayWeekMonth3 months
TEM−13.8%−12.8%+11.4%+25.7%
Application Leaders−0.2%+5.3%−1.9%—
Agentic Winners 40+0.2%+3.3%−2.8%—

Against the index: 16.1 pts behind on the week, 14.2 pts ahead on the month; against its Application Leaders sleeve 13.3 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Mentioned on Closelooknet 2 pieces · newest: Midday 10, “Yields reverse back through the buyback within hours — 10-year 4.692%, 30-year 5.234% — as Walmart's double beat is sold 9% and Bitcoin holds a new local high above 71,500” (2026-08-20)

Mentioned on Closelooknet

Where TEM appears in the diary — 2 pieces, newest first. Every link is our own writing.

Go deeper

Long reads

  • Agentic Application Software: The SaaSpocalypse MapDossier · $39 · 27 Feb 2026But AI agents in clinical workflows are coming: Tempus AI is building AI-native oncology tools, Intuitive Surgical is embedding AI in robotic surgery, and Veeva owns the regulatory data infrastructure for life sciences.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 1.35 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How TEM has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.35 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Tempus AI, Inc. Class A Common Stock moved 1.35% on average · correlation 0.17 · higher than 95% of US names
  • Beta, last 3 months 3.08 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.49% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +7.38% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Agentic Winners 40 · Application Leaders · 8 names with week and year-to-date

Peer group

Agentic Winners 40 · Application Leaders

Compared against TEM on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Tempus AI, Inc. Class A Common Stock

TEM in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Tempus AI is a healthcare technology company that links a clinician's desktop to laboratory diagnostics, genomic sequencing and an analytics platform holding multimodal patient data. It runs oncology-focused assays such as xT and xR, pharmacogenomic and inherited-condition tests, and licenses de-identified clinical and molecular data libraries called Insights to life-sciences researchers. It also builds Next, an AI platform, and Algos, algorithm-based diagnostic tools, and has research collaborations with several large drug makers.
Where it sits in the stack
Tempus AI carries no seat in our index; it sits within the diary's healthcare sector, in the health-information-services sleeve that pairs diagnostic testing with software.
Who it is priced against
Its peer group in the diary is Agentic Winners 40, Application Leaders, alongside Adobe, Intuit, Monday.com, Veeva, HubSpot, Atlassian, PTC and Dassault Systèmes; the market also compares it with Guardant Health.
Why Closelooknet tracks it
It carries a Closelooknet score with momentum the strongest module and quality the weakest; the diary's Dossier on agentic application software named it among firms building AI-native oncology tools, and a Midday update once quoted its share move.
What the diary watches
Whether AI-native oncology tools convert into recurring diagnostic revenue, and whether the weak capital-allocation reading improves as collaborations scale.

Tempus AI, Inc. Class A Common Stock (TEM) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: price target by Guggenheim, 2026-10-01

The Street on this name

Analyst actions and the latest print for TEM from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Guggenheim — target 92 from 65 Target raised to $92 from $65 (+13.3% to spot) 2026-10-01
  • Price target H.C. Wainwright — target 66 from 56 Target raised to $66 from $56 (+12.4% to spot) 2026-09-11

2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Tempus AI, Inc. Class A Common Stock (TEM)?

Tempus AI, Inc. Class A Common Stock trades as TEM on the US exchange in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is TEM in a Closelooknet index?

Not currently — Tempus AI, Inc. Class A Common Stock is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does TEM trade against its moving averages?

Up 9% at the close: Above both trend lines; one of the day's strongest moves. As of 2026-10-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is TEM doing against its Closelooknet index?

Over the past month Tempus AI, Inc. Class A Common Stock is +11.4% against −2.8% for the Agentic Winners 40 — 14.2 points ahead of its index, as of 2026-10-06. Its Application Leaders sleeve is −1.9% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does Tempus AI, Inc. Class A Common Stock compare with its peers?

Against its peer group (Agentic Winners 40 · Application Leaders), Tempus AI, Inc. Class A Common Stock (TEM) sits 19.9% below its 52-week high, 31.8% above its 50-day average; Adobe Systems Incorporated (ADBE) is 35.6% below, Intuit Inc (INTU) is 59.4% below, Monday.Com Ltd (MNDY) is 62.6% below. Put any of them next to TEM in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Tempus AI, Inc. Class A Common Stock trade when bond yields rise?

Over the past year Tempus AI, Inc. Class A Common Stock had a beta of 1.35 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 95% of US names. On the 10 sessions in which long bonds fell most it moved −1.49% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Tempus AI, Inc. Class A Common Stock?

Tempus AI, Inc. Class A Common Stock appears in 2 Closelooknet pieces, most recently Midday 10: Yields reverse back through the buyback within hours — 10-year 4.692%, 30-year 5.234% — as Walmart's double beat is sold 9% and Bitcoin holds a new local high above 71,500 (2026-08-20); Dossier: Agentic Application Software: The SaaSpocalypse Map (2026-02-27). What Closelooknet said most recently: NDSN adds 5.71% to 327.61, within reach of its 52-week high; TEM gains 7.10% to 65.60. (Midday 10, 2026-08-20). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

Does Closelooknet hold Tempus AI, Inc. Class A Common Stock?

Yes — AI Buildout: 200 shares · average entry $51.96, +38.5% unrealised. A record of what the diary does, not a recommendation to do the same.

What does Tempus AI, Inc. Class A Common Stock do?

Tempus AI is a healthcare technology company that links a clinician's desktop to laboratory diagnostics, genomic sequencing and an analytics platform holding multimodal patient data. It runs oncology-focused assays such as xT and xR, pharmacogenomic and inherited-condition tests, and licenses de-identified clinical and molecular data libraries called Insights to life-sciences researchers. It also builds Next, an AI platform, and Algos, algorithm-based diagnostic tools, and has research collaborations with several large drug makers. Its peer group in the diary is Agentic Winners 40, Application Leaders, alongside Adobe, Intuit, Monday.com, Veeva, HubSpot, Atlassian, PTC and Dassault Systèmes; the market also compares it with Guardant Health.

Where does Tempus AI, Inc. Class A Common Stock sit in the AI build-out?

Tempus AI carries no seat in our index; it sits within the diary's healthcare sector, in the health-information-services sleeve that pairs diagnostic testing with software. It carries a Closelooknet score with momentum the strongest module and quality the weakest; the diary's Dossier on agentic application software named it among firms building AI-native oncology tools, and a Midday update once quoted its share move.

What has Wall Street done on Tempus AI, Inc. Class A Common Stock recently?

The most recent analyst action on Tempus AI, Inc. Class A Common Stock on the Closelooknet wire is a price target by Guggenheim on 2026-10-01 (target 92 from 65). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TEM, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.